In this episode, we look at BetterLife Sciences (BETR.C), an emerging biotech company focused on the development and commercialization of cutting-edge treatments for mental disorders. We check out their product pipeline and stock price to get a better idea of what the future may hold for potential investors.
To Invest or Not: BetterLife Pharma (BETR.C)
Latest Articles
- Standard Uranium (STND.V): Now a triple threat as Sprott goes nuclear on uranium buy
- Zefiro Methane Corp (ZEFI.CBOE): Caps orphaned oil wells, cleans the environment, and makes money
- Victory lap: Five companies we told you about and how far up they’ve gone since
- Standard Uranium (STND.V) coverage sees stock rise 90% in three days
- The promo engine is revving on Magma Silver (MGMA.V)
Top Searches
Abitibi Greenstone Belt Barrick Gold best canadian cannabis company biotech Bitcoin blockchain bullion Canada cannabis CBD China Chris Parry covid cryptocurrency DEFN.V Fraser Institute gambling Gold gold price. gold prices Greg Nolan hemp inflation interest rates investing investments lithium Lukas Kane marijuana mining money Newmont Goldcorp Nexus Gold pharmaceuticals psychedelics resources shrooms stock market stocks technology trading uranium wealth wealth creation weed
by
Tags:
Leave a Reply